Yi Guo

机构：Shantou University, Cancer Hospital of Shantou University Medical College · ORCID：0000-0002-4208-0585

发表论文 17 篇 · 总被引 339 次 · h-index 8

代表论文

• Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial (2020 · Clinical Cancer Research · 被引 155)
• CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer (2014 · Oncology Reports · 被引 40)
• HPV16 integration probably contributes to cervical oncogenesis through interrupting tumor suppressor genes and inducing chromosome instability (2016 · Journal of Experimental & Clinical Cancer Research · 被引 29)
• Multi-state colposcopy image fusion for cervical precancerous lesion diagnosis using BF-CNN (2021 · Biomedical Signal Processing and Control · 被引 27)
• Computer-aided diagnosis of gastrointestinal stromal tumors: a radiomics method on endoscopic ultrasound image (2019 · International Journal of Computer Assisted Radiology and Surgery · 被引 26)
• Prostasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin (2014 · Cell Death and Disease · 被引 24)